Michael Kassiou

Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists

Alexander Gillis, Arisbel B. Gondin, Andrea Kliewer et al. · Science Signaling · 2020 · 350 citations · Full text

Biased Agonism, Opioid Epidemic, Pain Medicine +23

DPA-714, a New Translocator Protein–Specific Ligand: Synthesis, Radiofluorination, and Pharmacologic Characterization

Michelle L. James, Roger Fulton, Johnny Vercoullie et al. · Journal of Nuclear Medicine · 2008 · 268 citations · Full text

Pharmacology of Valinate and<i>tert</i>-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues

Samuel D. Banister, Mitchell Longworth, Richard C. Kevin et al. · ACS Chemical Neuroscience · 2016 · 246 citations

Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study

Jennifer M. Coughlin, Yuchuan Wang, Cynthia A. Munro et al. · Neurobiology of Disease · 2014 · 241 citations · Full text

Former Nfl Players, Medicine, Vivo Multimodal +11

Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA

Samuel D. Banister, Michael Moir, Jordyn Stuart et al. · ACS Chemical Neuroscience · 2015 · 239 citations

Cannabis Use, Medicinal Chemistry, Drug Target +14